Ed Biotech announced that the company uses centralized bidding to repurchase shares to cancel and reduce registered capital. The total repurchase capital is not less than 100 million yuan and no more than 200 million yuan. The implementation period is 12 months from the date the shareholders' meeting reviews and approves the repurchase plan. As of January X, 2026, the company had repurchased a total of 9.119 million shares, accounting for 2.34% of the total share capital. The highest transaction price was 22.53 yuan/share, the lowest transaction price was 15.68 yuan/share, and the total payment amount was about 171 million yuan. This repurchase complies with the established plan and relevant regulations, and the company will continue to implement the repurchase plan during the repurchase period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.